跳至主要内容
临床试验/EUCTR2008-006863-35-SE
EUCTR2008-006863-35-SE进行中(未招募)不适用

Prophylactic photodynamic therapy for organ transplant patients – arandomised, intra-individual trial with blinded outcome evaluation.

Bispebjerg Hospital0 个研究点目标入组 50 人开始时间: 2013年7月9日最近更新:
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Patients who have undergone a kidney transplant at least 1 year ago.
  • Patients who have given written informed consent and are considered willing to follow the trial protocol.
  • Patients aged 40 years or older.
  • Patients with fair skin type defined as Fitzpatrick skin type I-III.
  • Fertile women must use a reliable form of contraception.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 50
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • Patients under 40 and over 70 years of age.
  • Patients who have received PDT treatment in the areas under
  • investigation.
  • Patients with dark skin type defined as Fitzpatrick skin type IV-VI.
  • Patients, have signs of dysplastic skin changes in the areas
  • under investigation, such as warts, AK, NMSC, Bowen's disease,
  • keratoacanthoma or infiltrative tumours.
  • Patients known to have an allergy to any constituents of the MAL cream
  • Pregnant or breast-feeding patients.

研究者

相似试验